NYSEARCA:LCTX
Lineage Cell Therapeutics, Inc. Stock News
$1.08
+0.0200 (+1.89%)
At Close: May 17, 2024
Maxim Group Gives a Buy Rating to Titan Pharmaceuticals (TTNP) - Markets
05:24pm, Thursday, 25'th Jun 2020
Maxim Group analyst Jason McCarthy assigned a Buy rating to Titan Pharmaceuticals (TTNP – Research Report) today and set a
Soligenix (SNGX) Receives a Buy from Maxim Group - Markets
05:16pm, Thursday, 25'th Jun 2020
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to Soligenix (SNGX – Research Report),
Lineage Cell Therapeutics Provides Update on OPC1 Cell Therapy Program for Spinal Cord Injury
12:00pm, Thursday, 25'th Jun 2020
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today provided an update on OPC1, the Co
Lineage Cell Therapeutics Provides Update on OPC1 Cell Therapy Program for Spinal Cord Injury
12:00am, Thursday, 25'th Jun 2020
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medic
Reuters Health News Summary
01:00pm, Wednesday, 24'th Jun 2020
There were 2,531 new coronavirus infections reported in the past 24 hours, raising the total number of cases to 212,501, along with 9,996 deaths in all, the ministry said on Wednesday.
Lineage Cell Therapeutics to Present OpRegen® Data at International Society for Stem Cell Research (ISSCR) 2020 Virtual Annual Meeting
12:00pm, Wednesday, 24'th Jun 2020
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced that interim results fro
Lineage Cell Therapeutics to Present OpRegen® Data at International Society for Stem Cell Research (ISSCR) 2020 Virtual Annual Meeting
12:00am, Wednesday, 24'th Jun 2020
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medic
Maxim Group Thinks BioNano Genomics' Stock is Going to Recover - Markets
01:09pm, Tuesday, 23'rd Jun 2020
In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on BioNano Genomics (BNGO – Research
Lineage Cell Therapeutics (LCTX) Gets a Buy Rating from H.C. Wainwright - Markets
11:33am, Monday, 22'nd Jun 2020
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Lineage Cell Therapeutics (LCTX – Research Report) on June 18
Maxim Group Assigns a Buy Rating on Heat Biologics (HTBX) - Markets
05:31pm, Friday, 19'th Jun 2020
Maxim Group analyst Jason McCarthy assigned a Buy rating to Heat Biologics (HTBX – Research Report) today and set a
Annovis Bio (ANVS) Initiated with a Buy at Maxim Group - Markets
11:16am, Friday, 19'th Jun 2020
Maxim Group analyst Jason McCarthy initiated coverage with a Buy rating on Annovis Bio (ANVS – Research Report) today and
The Global Allogeneic Stem Cells Market will grow by USD 1.24 bn during 2020-2024
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage cell therapy company which manufactures and transplants specific cell types to treat diseases and serious medical condi
H.C. Wainwright Keeps Their Buy Rating on Armata Pharmaceuticals (ARMP) - Markets
12:58pm, Wednesday, 17'th Jun 2020
H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Armata Pharmaceuticals (ARMP – Research Report) today and set a
Lineage Cell Therapeutics to Present Tomorrow at 2020 Raymond James Human Health Innovation Conference
12:00pm, Wednesday, 17'th Jun 2020
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced that Brian M. Culley, Chief Ex
